Vaccination against microbiota motility protects mice from the detrimental impact of dietary emulsifier consumption

PLoS Biol. 2023 Sep 19;21(9):e3002289. doi: 10.1371/journal.pbio.3002289. eCollection 2023 Sep.

Abstract

Dietary emulsifiers, including carboxymethylcellulose (CMC) and polysorbate 80 (P80), perturb gut microbiota composition and gene expression, resulting in a microbiota with enhanced capacity to activate host pro-inflammatory gene expression and invade the intestine's inner mucus layer. Such microbiota alterations promote intestinal inflammation, which can have a variety of phenotypic consequences including increased adiposity. Bacterial flagellin is a key mediator of emulsifiers' impact in that this molecule enables motility and is itself a pro-inflammatory agonist. Hence, we reasoned that training the adaptive mucosal immune system to exclude microbes that express flagellin might protect against emulsifiers. Investigating this notion found that immunizing mice with flagellin elicited an increase in mucosal anti-flagellin IgA and IgA-coated microbiota that would have otherwise developed in response to CMC and P80 consumption. Yet, eliciting these responses in advance via flagellin immunization prevented CMC/P80-induced increases in microbiota expression of pro-inflammatory agonists including LPS and flagellin. Furthermore, such immunization prevented CMC/P80-induced microbiota encroachment and deleterious pro-inflammatory consequences associated therewith, including colon shortening and increased adiposity. Hence, eliciting mucosal immune responses to pathobiont surface components, including flagellin, may be a means of combatting the array of inflammatory diseases that are promoted by emulsifiers and perhaps other modern microbiota stressors.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Diet
  • Flagellin
  • Immunization
  • Immunoglobulin A
  • Mice
  • Microbiota*
  • Obesity
  • Polysorbates / pharmacology
  • Vaccination*

Substances

  • Flagellin
  • Polysorbates
  • Immunoglobulin A

Grants and funding

This work was supported by a Starting Grant from the European Research Council (ERC) under the European Union’s Horizon 2020 research and innovation program (grant agreement No. ERC-2018-StG- 804135 to BC), a Chaire d’Excellence from IdEx Université de Paris - ANR-18-IDEX-0001 to BC, an Innovator Award from the Kenneth Rainin Foundation to BC, an award from the Fondation de l'avenir (AP-RM-21-032 to BC), ANR grants EMULBIONT (ANR-21-CE15-0042-01 to BC) and DREAM (ANR-20-PAMR-0002 to BC) and the national program “Microbiote” from INSERM to BC. MK is supported by a Postdoc Fellowship from the Fondation pour la Recherche Médicale (FRM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.